Filing Details
- Accession Number:
- 0001437749-14-016954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-12 19:39:50
- Reporting Period:
- 2014-09-10
- Filing Date:
- 2014-09-12
- Accepted Time:
- 2014-09-12 19:39:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123979 | Senomyx Inc | SNMX | Services-Commercial Physical & Biological Research (8731) | 330843840 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1473300 | E Antony Rogers | 4767 Nexus Centre Dr. San Diego CA 92121 | Senior V.p. & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-10 | 14,800 | $8.74 | 60,815 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-10 | 14,800 | $9.00 | 46,015 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2014-09-10 | 14,800 | $0.00 | 14,800 | $8.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-01-19 | No | 4 | M | Direct |
Footnotes
- The options exercised were scheduled to expire on January 19, 2015.
- Includes 6,221 shares of Common Stock that were acquired by the Reporting Person on 8/29/14, pursuant to the Issuer's Employee Stock Purchase Plan.
- Reported transaction occurred pursuant to Rule 10B5-1 Plan.
- In addition to the 46,015 shares of Common Stock beneficially owned, the Reporting Person also holds outstanding options to purchase 785,720 shares of Common Stock.
- The shares subject to the option are fully vested.